Sex-specific mortality prediction by pro-C-type natriuretic peptide measurement in a prospective cohort of patients with ST-elevation myocardial infarction

Objective To determine the predictive value of pro-C-type natriuretic peptide (pro-CNP) measurement in plasma sampled on admission from patients presenting with ST-elevation myocardial infarction (STEMI). Design Prospective cohort study. Setting Two University Hospitals in Denmark. Participants 1760 consecutive patients (470 females and 1290 males) with confirmed STEMI. Main outcomes and measures The main outcome was all-cause mortality at 1 year after presentation and the primary measure was pro-CNP concentration in plasma at admission in all patients and longitudinal measurements in a consecutive subgroup of 287 patients. A reference population (n=688) defined cut-off values of increased pro-CNP concentrations. Results In all patients, an increased pro-CNP concentration was associated with a higher all-cause mortality after 1 year (HR 1.6, 95% CI 1.1 to 2.4, Plogrank=0.009) including an interaction of sex (p=0.03). In separate sex-stratified analyses, female patients showed increased all-cause mortality (HR1 year 2.6, 95% CI 1.5 to 4.6), Plogrank <0.001), whereas no differences were found in male patients (HR1 year 1.1, 95% CI 0.7 to 1.9, Plogrank=0.66). After adjusting for potential risk factors, we found increased pro-CNP concentrations≥the median value to be independently associated with increased risk of mortality in female patients within 1 year (HR per 1 pmol/L increase: 1.04, 95% CI 1.01 to 1.06, p=0.007). Moreover, we found indications of sex differences in pro-CNP concentrations over time (higher pro-CNP in males (4.4, 95% CI −0.28 to 9.1 pmol/L, p=0.07) and interaction of sex and time (p=0.13)), and that hypertension was independently associated with higher pro-CNP (4.5, 95% CI 0.6 to 8.4 pmol/L, p=0.03). Conclusions In female but not male patients presenting with STEMI, high concentrations of pro-CNP (≥median) at admission independently indicate a higher risk of all-cause mortality. The findings are remarkably specific for female patients, suggesting a different vascular phenotype beyond traditional measures of coronary artery flow compared with male patients.

[1]  B. Bruneau,et al.  Cardiac natriuretic peptides , 2020, Nature Reviews Cardiology.

[2]  D. Abraham,et al.  Endothelial C-Type Natriuretic Peptide Is a Critical Regulator of Angiogenesis and Vascular Remodeling , 2019, Circulation.

[3]  K. Margulies,et al.  C-type natriuretic peptide co-ordinates cardiac structure and function , 2019, European heart journal.

[4]  R. Adams,et al.  Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure , 2018, Circulation.

[5]  C. Hassager,et al.  Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients , 2018, European heart journal. Acute cardiovascular care.

[6]  J. Goetze,et al.  Processing-independent proANP measurement for low concentrations in plasma: reference intervals and effect of body mass index and plasma glucose , 2017, Clinical chemistry and laboratory medicine.

[7]  K. Nakao,et al.  Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity , 2017, Hypertension.

[8]  R. Doughty,et al.  C-Type Natriuretic Peptides in Coronary Disease. , 2017, Clinical chemistry.

[9]  H. D. den Ruijter,et al.  Sex matters to the heart: A special issue dedicated to the impact of sex related differences of cardiovascular diseases. , 2015, Atherosclerosis.

[10]  K. Bailey,et al.  Circulating C-Type Natriuretic Peptide and Its Relationship to Cardiovascular Disease in the General Population , 2015, Hypertension.

[11]  H. Hillege,et al.  Prognostic value of N‐terminal pro C‐type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction , 2014, European journal of heart failure.

[12]  A. Richards,et al.  C-type natriuretic peptide (CNP) signal peptide fragments are present in the human circulation. , 2014, Biochemical and biophysical research communications.

[13]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[14]  V. Cameron,et al.  Impact of age, phenotype and cardio‐renal function on plasma C‐type and B‐type natriuretic peptide forms in an adult population , 2013, Clinical endocrinology.

[15]  Maarten L. Simoons,et al.  The third universal definition of myocardial infarction , 2013 .

[16]  N. Koles,et al.  Regulation of C-type natriuretic peptide expression , 2011, Peptides.

[17]  J. Rehfeld,et al.  Measurement of the total proANP product in mammals by processing independent analysis. , 2011, Journal of immunological methods.

[18]  J. Rehfeld,et al.  Processing-independent analysis for pro-C-type natriuretic peptide. , 2010, Journal of immunological methods.

[19]  S. Palmer,et al.  Regional Release and Clearance of C-Type Natriuretic Peptides in the Human Circulation and Relation to Cardiac Function , 2009, Hypertension.

[20]  G. Rosano,et al.  Gender differences in the cardiovascular effect of sex hormones , 2009, Nature Reviews Cardiology.

[21]  A. Richards,et al.  Effect of sex steroids on plasma C-type natriuretic peptide forms: stimulation by oestradiol in lambs and adult sheep. , 2008, The Journal of endocrinology.

[22]  Yuzhi Zhang,et al.  Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. , 2005, The Journal of clinical investigation.

[23]  A. Clerico,et al.  [The cardiac natriuretic peptides]. , 2006, Minerva medica.

[24]  R. Karas,et al.  Molecular and Cellular Basis of Cardiovascular Gender Differences , 2005, Science.

[25]  H. E. Solberg,et al.  The IFCC recommendation on estimation of reference intervals. The RefVal Program , 2004, Clinical chemistry and laboratory medicine.

[26]  P. H. Petersen,et al.  Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the Nordic Reference Interval Project 2000 , 2004, Scandinavian journal of clinical and laboratory investigation.

[27]  Zhaohui Zhang,et al.  Shear Stress Induction of C-type Natriuretic Peptide (CNP) in Endothelial Cells is Independent of NO Autocrine Signaling , 1999, Annals of Biomedical Engineering.

[28]  Rehfeld Jf,et al.  The posttranslational phase of gene expression: new possibilities in molecular diagnosis. , 2003 .

[29]  V. Miller,et al.  Gender and relaxation to C-type natriuretic peptide in porcine coronary arteries. , 1998, Journal of cardiovascular pharmacology.

[30]  N. Tamura,et al.  Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. , 1997, Hypertension.

[31]  M. Pittelkow,et al.  Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. , 1992, The American journal of physiology.